Literature DB >> 25684527

Clinico-hematological profile of patients with B-chronic lymphoid leukemia in Pakistan.

Rozina Zeeshan1, Sadia Sultan, Syed Muhammad Irfan, Jamaludin Kakar, Muhammad Asif Hameed.   

Abstract

BACKGROUND: Chronic lymphoid leukemia (CLL) is not an uncommon hematological malignancy which primarily affects elderly individuals. It is more common in developed world than in developing countries. The rational of this study was to determine the clinico-hematological profile in Pakistan.
MATERIALS AND METHODS: In this prospective cross sectional study, sixty patients with CLL were enrolled from January 2011 to June 2013. Data were analyzed with SPSS version 21.
RESULTS: The mean age was 59.0±9.2 years (range 40-82) and the male to female ratio was 2.1:1. Peak age group was 60-70 years (38.3%) and 18.3% were under 50 years old. Major complaints were weakness (51.7%), fever (18.3%) and abdominal discomfort (13.3%). Main clinical findings were splenomegaly (46.6%), lymphadenopathy (36.6%) and pallor (26.7%). Some 16.7% were diagnosed incidentally. The mean hemoglobin was 10.8±2.4 g/dl, with a total leukocyte count of 91.5±87.8x10(9)/l and platelets 197.8±103.2x10(9)/l. Anemia and thrombocytopenia were seen in 26.7% and 21.7% of cases, respectively. High LDH and hyperuricemia were detected in 15% each and elevated serum creatinine was seen in 11.6%. According to Rai staging 11.6% were in stage 0, 13.3% stage 1, 26.7% each for stage II and stage III while 21.7% patients were in stage IV.
CONCLUSIONS: CLL in our patients in Pakistan, unlike in the West, is seen in a relatively young population with male predominance. Primarily disease is of B- cell origin and about 2/3 of the patients present at advanced stage.

Entities:  

Mesh:

Year:  2015        PMID: 25684527     DOI: 10.7314/apjcp.2015.16.2.793

Source DB:  PubMed          Journal:  Asian Pac J Cancer Prev        ISSN: 1513-7368


  2 in total

1.  Trends in Disease Burden of Chronic Lymphocytic Leukemia at the Global, Regional, and National Levels From 1990 to 2019, and Projections Until 2030: A Population-Based Epidemiologic Study.

Authors:  Yang Ou; Yichen Long; Lili Ji; Yanxia Zhan; Tiankui Qiao; Xiangdong Wang; Hao Chen; Yunfeng Cheng
Journal:  Front Oncol       Date:  2022-03-10       Impact factor: 6.244

2.  Suppression of HSP27 increases the anti‑tumor effects of quercetin in human leukemia U937 cells.

Authors:  Xi Chen; Xiu-Shuai Dong; Hai-Yan Gao; Yong-Fang Jiang; Ying-Lan Jin; Yu-Ying Chang; Li-Yan Chen; Jing-Hua Wang
Journal:  Mol Med Rep       Date:  2015-11-23       Impact factor: 2.952

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.